Aromics Biotech

About:

AROMICS is committed to the discovery and development of novel drugs and diagnostic methods to target relevant human health diseases.

Website: http://www.aromics.es/

Twitter/X: aromics

Top Investors: Capital Cell, EASME - EU Executive Agency for SMEs

Description:

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life. They believe that OMIC technologies represent an important first step towards gaining biological insights into: How drugs work, giving them added value, reducing attrition rates and advancing through the clinic. Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

Total Funding Amount:

1.85M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2005-01-01

Contact Email:

rrhh(AT)aromics.es

Founders:

Narcís Clavell

Number of Employees:

1-10

Last Funding Date:

2019-02-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai